GSK Investigational Site

Konin 62-500

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Thrombocytopaenia

Studies at this site

• A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma — Completed
• Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag — Completed